Are you over 21?
I confirm that I am 21 years of age or older and understand that certain products on this site are for research use only. I agree to the terms and conditions.
I confirm that I am 21 years of age or older and understand that certain products on this site are for research use only. I agree to the terms and conditions.
GLP-3 R is a triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. As a triple incretin agonist, it represents the leading edge of metabolic peptide research and has garnered significant attention for its early clinical results.
The triple-agonist mechanism engages three distinct but complementary pathways: GLP-1 and GIP receptor activation modulates insulin secretion and appetite signaling, while glucagon receptor agonism drives hepatic glucose output and energy expenditure. Phase 2 clinical data published in the New England Journal of Medicine has reported weight reduction outcomes that have attracted wide scientific interest in the field of metabolic medicine.
GLP-3 R is supplied as a lyophilized powder at multiple concentrations, independently verified to ≥99% purity by HPLC and mass spectrometry.